Skip to main content

Alex Rovira Cañellas

I am a full time diagnostic neuroradiologist, who gained his MD in 1983 at the Autonomos University of Barcelona. After formal training in Radiology at Vall d’Hebron University Hospital (Barcelona), I undertook a visiting fellowship at Shands Hospital (Gainesville, University of Florida) in 1989. In 1990, I became staff neuroradiologist at the Section of Neuroradiology at Vall d’Hebron Hospital. At present I am Director of the Section of Neuroradiology at University Hospital Vall d’Hebron, Barcelona (Spain).

Institutions of which they are part

Head of group
Neuroradiology
Vall Hebron Institut de Recerca
Cap de Secció
Radiodiagnòstic (IDI)
Cross-departmental services
I am Professor of Neuroimmunology at the Autonomous University of Barcelona, and Honorary Associate Professor at the University College of London.
I am specialised in diagnostic neuroradiology, and head and neck radiology, with particular interest in demyelinating diseases, stroke, neuro-oncology, and neurodegenerative disorders.
I am currently Executive Committee Member of the Spanish Society of Radiology, of the International Society of Radiology, and of the World Federation of Neuroradiological Societies, member of the Research Committee de la European Society of Radiology and steering committee member of MAGNIMS (European Multicenter Collaborative Research Network on MRI in MS).
I am on the editorial boards of the Neurology and Neuroradiology, and served served as President of the European Society of Neuroradiology (2016-2018), as President of the Spanish Society of Neuroradiology (2009-2015), on the Lucien Appel Prize Award Jury of the European Society of Neuroradiology (2006-2012), as Editor of Neuroradiology in the Spanish Journal of Radiology, as Director of the 10th and 11th Cycles of the Pierre Lasjaunias European Course of Neuroradiology (2008-2012), and as Chairman of MAGNIMS (2012-2018). I am author/co-author of 500 articles (Scopus; total citations 14,818; h-index: 83), 30 book chapters or monographs, and more than 400 invited conference presentations. I am also editor of three books: “Essential Radiology” (Panamericana 2019), “Clinical Neuroradiology” (Springer 2019), and “Controversies in Radiology” (Aran 2020). I have been invited as Visiting Professor at University of Toronto, at McGill University (Montreal), at Lysholm Department of Neuroradiology (UCL, London), at Otawa University, and at University of North Carolina (Chapel Hill). I am honorary member of the Paulista Society of Radiology, and of the Polish Society of Radiology.

Research lines

Application of MRI imaging to the study of Parkinson's disease

The aim of the line is to evaluate the added value of the information provided by MRI techniques, mainly aimed at the evaluation of melanin, myelin, presence of Fe, structural and functional connectivity in the study of Parkinson’s disease.

IP: Fco. Javier Aymerich Martínez, Alex Rovira Cañellas

Application of MR imaging and spectroscopy techniques to the study of multiple sclerosis

This research line is focused on studying the diagnostic and prognostic value of magnetic resonance imaging variables in multiple sclerosis (MS). Other current interests include the study of the added value of the consideration of cortical lesions in the diagnostic criteria as well as the role of SWI in the differential diagnosis of MS in respect to other diseases that present lesions similar to the ones found in MS

IP: Alex Rovira Cañellas

Application of MRI in multiple sclerosis and other demyelinating diseases

The objective of this research line is to evaluate the value of MRI in the diagnosis of multiple sclerosis and as a marker of progression and treatment response to disease modifying treatments.

IP: Alex Rovira Cañellas, Cristina Auger Acosta

Research in Cerebrovascular Diseases

This research line is mainly focused on the assessment of intracranial aneurysms. This includes the role of several imaging techniques to predict the risk of future rupture. Other interests are to associate imaging changes with the pathophysiological mechanisms that underlie aneurysm formation and to optimize the imaging protocol used in clinical practice.

IP: Alex Rovira Cañellas

Projects

BIOMARCADORS D'ATRÒFIA I DE LESIONS EN IMATGES DE RESSONÀNCIA MAGNÈTICA DE PACIENTS AMB ESCLEROSI MÚLTIPLE.

IP: Alex Rovira Cañellas
Collaborators: -
Funding agency:
Funding:
Reference: PR(AG)259/2019
Duration: -

RETROSPECTIVE ANALYSIS OF ADVANCED MRI IN BRAIN TUMOUR PATIENTS.

IP: Alex Rovira Cañellas
Collaborators: -
Funding agency:
Funding:
Reference: PR(AG)148/2019
Duration: -

TRAtamiento y recuperación VISual en neuritis óptica - Estudio TRAVIS

IP: Jaume Sastre Garriga
Collaborators: Dulce María Moncho Rodríguez, Sergio Cabello , Cristina Auger Acosta, Alex Rovira Cañellas, Merce Bonastre Garcia, Ana Zabalza de Torres, Joaquin Castillo Justribo, Anna Laura Salerno
Funding agency: Instituto de Salud Carlos III
Funding: 96800
Reference: PI19/00950
Duration: 01/01/2020 - 31/12/2022

"Estudi pilot sobre la detecció de 2-hidroxiglutarat per espectroscòpia de ressonància magnètica"

IP: Alex Rovira Cañellas
Collaborators: -
Funding agency:
Funding:
Reference: PR(AG)01/2018
Duration: -

Related news

Els doctors Xavier Montalban, Àlex Rovira i Mar Tintoré han estat reconeguts en la categoria de Neurociències i Comportament, i el doctor Jordi Rello en la categoria Interdisciplinària.

The program, promoted by Biocat in collaboration with CIMIT (Boston), is aimed at entrepreneurs in the process of bringing their technology to market in the next few years.

Related professionals

Constanza Daigre Blanco

Constanza Daigre Blanco

Research technician
Psychiatry, Mental Health and Addictions
Read more
Fernando Clau Terre

Fernando Clau Terre

Read more
Montserrat Cubo Abert

Montserrat Cubo Abert

Biomedical Research in Gynaecology
Read more
Alejandro Gines  Puertas

Alejandro Gines Puertas

Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.